Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Axim Biotechnologies Inc (QB) | AXIM | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.0215 | 07:01:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0215 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0159 - 0.118 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.0215 | USD |
Axim Biotechnologies Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.89M | 227.65M | 39.53M | 9k | -6.24M | -0.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Axim Biotechnologies (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AXIM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0286 | 0.0299 | 0.02 | 0.0227427 | 398,752 | -0.0071 | -24.83% |
| 1 Month | 0.0226 | 0.0329 | 0.0188 | 0.0244896 | 402,266 | -0.0011 | -4.87% |
| 3 Months | 0.0359 | 0.036 | 0.0188 | 0.0265035 | 350,769 | -0.0144 | -40.11% |
| 6 Months | 0.0314 | 0.055 | 0.0163 | 0.0270468 | 311,715 | -0.0099 | -31.53% |
| 1 Year | 0.09305 | 0.118 | 0.0159 | 0.0310758 | 357,422 | -0.07155 | -76.89% |
| 3 Years | 0.66 | 1.22 | 0.0159 | 0.2140945 | 298,760 | -0.6385 | -96.74% |
| 5 Years | 1.91 | 2.50 | 0.0159 | 0.409609 | 277,426 | -1.89 | -98.87% |
Axim Biotechnologies (QB) Description
| Axim Biotechnologies, Inc. is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axim's core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays. |